KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Net Income: 2009-2024

Historic Net Income for Rigel Pharmaceuticals (RIGL) over the last 16 years, with Dec 2024 value amounting to $17.5 million.

  • Rigel Pharmaceuticals' Net Income rose 124.62% to $27.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $113.2 million, marking a year-over-year increase of 2817.96%. This contributed to the annual value of $17.5 million for FY2024, which is 169.61% up from last year.
  • According to the latest figures from FY2024, Rigel Pharmaceuticals' Net Income is $17.5 million, which was up 169.61% from -$25.1 million recorded in FY2023.
  • In the past 5 years, Rigel Pharmaceuticals' Net Income registered a high of $17.5 million during FY2024, and its lowest value of -$58.6 million during FY2022.
  • In the last 3 years, Rigel Pharmaceuticals' Net Income had a median value of -$25.1 million in 2023 and averaged -$22.1 million.
  • Per our database at Business Quant, Rigel Pharmaceuticals' Net Income crashed by 226.97% in 2022 and then spiked by 169.61% in 2024.
  • Over the past 5 years, Rigel Pharmaceuticals' Net Income (Yearly) stood at -$29.7 million in 2020, then surged by 39.77% to -$17.9 million in 2021, then crashed by 226.97% to -$58.6 million in 2022, then spiked by 57.16% to -$25.1 million in 2023, then soared by 169.61% to $17.5 million in 2024.